Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma
- PMID: 37950590
- DOI: 10.1002/hed.27570
Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma
Abstract
Introduction: The underlying factors that contribute to early radiotherapy (RT) termination are understudied, especially in the era of hypofractionated treatment regimens. In this retrospective investigation, we examined the characteristics and causes of premature RT terminations in senior adults (>70 years old) with oral cavity (OC) and laryngeal carcinomas.
Methods: Hundred and eighty-eight patients treated with RT ± systemic therapy for OC and laryngeal cancer from 2017 to 2022 were identified. Premature termination was defined as completion of less than 95% of the prescribed RT. Logistic regression analysis was performed to examine factors predictive of premature termination, and survival was determined using the Kaplan-Meier method.
Results: Twenty patients (10.6%) experienced premature RT terminations. On regression analysis, ECOG score at initiation of RT was the only covariate studied to be independently associated with premature termination (OR 2.00, 95%CI: [1.21, 3.30], p = 0.007). Three-year overall survival (49.1% vs. 77.3%) was significantly reduced in the termination cohort (p < 0.0001).
Conclusions: This analysis demonstrated over 1 in 10 patients had premature RT termination, which prognosticated inferior survival outcomes. Poor performance status may highlight patients at risk for premature termination and thus identify good candidates for hypofractionated protocols.
Keywords: head and neck cancer; larynx; oral cavity; performance status; radiotherapy termination.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Bureau UC. Demographic turning points for the United States: population projections for 2020 to 2060. https://www.census.gov/library/publications/2020/demo/p25-1144.html. Accessed May 10, 2023
-
- Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol off J Am Soc Clin Oncol. 2009;27(17):2758-2765. doi:10.1200/JCO.2008.20.8983
-
- Butkus JM, Crippen M, Bar-Ad V, Luginbuhl A. Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival. Front Oncol. 2022;12:973245. doi:10.3389/fonc.2022.973245
-
- Eytan DF, Blackford AL, Eisele DW, Fakhry C. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States. Cancer. 2019;125(2):249-260. doi:10.1002/cncr.31800
-
- Lewis CM, Hessel AC, Roberts DB, et al. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Neck Surg. 2010;136(12):1205-1211. doi:10.1001/archoto.2010.206
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
